Bacteriophages of Pseudomonas tolaasii for the Biological Control of Brown Blotch Disease

被引:21
作者
Kim, Min-Hee [1 ]
Park, Seong-Wan [1 ]
Kim, Young-Kee [1 ]
机构
[1] Chungbuk Natl Univ, Dept Environm & Biol Chem, Cheongju 361763, South Korea
来源
JOURNAL OF THE KOREAN SOCIETY FOR APPLIED BIOLOGICAL CHEMISTRY | 2011年 / 54卷 / 01期
关键词
bacteriophage; brown blotch disease; oyster mushroom; phage therapy; Pseudomonas tolaasii; GROWTH; PHAGES;
D O I
10.3839/jksabc.2011.014
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Pseudomonas tolaasii causes brown blotch disease in cultivated mushrooms by producing tolaasin, a peptide toxin, which forms pores on the membrane and disrupts the cellular and fruiting body structures of mushrooms. For the biological control of this mushroom disease, virulent bacteriophages of P totaasii were isolated from the sewage of Cheongju, Korea. Twenty-one phages were isolated from four different locations, and their toxicities to host bacteria were measured by inspecting the turbidity and size of their plaques. They were divided into three categories on the basis of their toxicities to host bacteria. In order to test if these phages can be used for the biological control of mushroom diseases, a pitting test was performed. The surfaces of mushroom caps were inoculated with both pathogenic bacteria and their phages. Phage toxicity was analyzed by measuring the size of the blotches that formed on the surface of mushrooms, because these sizes are representative of the amount of tolaasin peptide produced by pathogenic bacteria in the presence of bacteriophages. The formation of blotches was completely blocked by co-incubated phages. These results show that phages can sterilize pathogenic bacteria in mushroom tissues as well as be useful for the biological control of brown blotch disease. The optimum conditions for the bactericidal activity of the phages were also determined.
引用
收藏
页码:99 / 104
页数:6
相关论文
共 25 条
  • [1] Adams MH, 1959, BACTERIOPHAGES, DOI 10.5962/bhl.title.6966
  • [2] Chakrabarti AK, 2000, J CLIN MICROBIOL, V38, P44
  • [3] Phages and their application against drug-resistant bacteria
    Chanishvili, N
    Chanishvili, T
    Tediashvili, M
    Barrow, PA
    [J]. JOURNAL OF CHEMICAL TECHNOLOGY AND BIOTECHNOLOGY, 2001, 76 (07) : 689 - 699
  • [4] In vitro and in vivo bacteriolytic activities of Escherichia coli phages:: Implications for phage therapy
    Chibani-Chennoufi, S
    Sidoti, J
    Bruttin, A
    Kutter, E
    Sarker, S
    Brüssow, H
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (07) : 2558 - 2569
  • [5] Transfer of conjugative plasmids and bacteriophage λ occurs in the presence of antibiotics that prevent de novo gene expression
    Cooper, TF
    Heinemann, JA
    [J]. PLASMID, 2000, 43 (02) : 171 - 175
  • [6] Gandy D. G., 1968, Annual Report Glasshouse Crops Research Institute 1967, P150
  • [7] PSEUDOMONAS TOLAASII CONTROL BY KASUGAMYCIN IN CULTIVATED MUSHROOMS (AGARICUS-BISPORUS)
    GEELS, FP
    [J]. JOURNAL OF APPLIED BACTERIOLOGY, 1995, 79 (01): : 38 - 42
  • [8] GEELS FP, 1991, SCI CULTIVATION EDIB, V1, P437
  • [9] Bacteriophage control of foodborne bacteria
    Greer, GG
    [J]. JOURNAL OF FOOD PROTECTION, 2005, 68 (05) : 1102 - 1111
  • [10] GUILLAUMES J, 1998, B OEPP EPPO, V18, P77